Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

PRANA BIOTECHNOLOGY LIMITED ADR

WKN: 753907  ISIN: US7397271054  Ticker-Symbol: PBNA 
Aktie:
Branche
Biotechnologie
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
PRANA BIOTECHNOLOGY LIMITED ADR Chart 1 Jahr
1-Woche-Intraday-Chart
PRANA BIOTECHNOLOGY LIMITED ADR 1-Woche-Intraday-Chart

Aktuelle News zur PRANA BIOTECHNOLOGY LIMITED ADR Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
21.05. 1
18.05. 1
09.05. 17
MELBOURNE, AUSTRALIA -- (Marketwire) -- 05/09/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that Professor Rudy Tanzi, the Joseph P. and Rose F. Kennedy Professor of Neurology...
Mehr lesen zu:
Prana Chief Scientific Advisor to Give Plenary Lecture at Alzheimer's Symposium in Stockholm Featuring New Targets and Drugs / Dr. Rudy Tanzi to Discuss PBT2 Trial on Thursday, May 10
09.05. 1
04.05. 2
01.05. 24
MELBOURNE, AUSTRALIA -- (Marketwire) -- 05/01/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today commented on the publication of new data of relevance to the current clinical trial, testing...
Mehr lesen zu:
Prana Comments on Archives of Neurology Publication Which Highlights Critical Role of Brain Metals in Huntington Disease Progression / MGH Team Publishes Data That Supports the Use of PBT2 in Huntington Disease
01.05. 1
01.05. -
30.04. 19
MELBOURNE, AUSTRALIA -- (Marketwire) -- 04/30/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that the first patient has been dosed in the "Reach2HD Trial" - a 6 month Phase IIa...
Mehr lesen zu:
Prana Enrolls First Patient in the "Reach2HD" Phase II Huntington Disease Trial / Huntington Study Group Initiates First Site at University of California, San Diego School of Medicine
27.04. 1
17.04. 2
30.03. 4
26.03. 46
MELBOURNE, AUSTRALIA -- (Marketwire) -- 03/26/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced the publication, in the journal PLoS ONE, of an article that strongly endorses PBT2's...
Mehr lesen zu:
PLoS ONE Journal Publishes Mechanistic Model of Alzheimer's Disease Endorsing Prana's PBT2
26.03. 1
21.03. 2
07.03. 19
MELBOURNE, AUSTRALIA -- (Marketwire) -- 03/07/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that the first patient has been dosed in the "IMAGINE Trial" -- 12 month Phase II...
Mehr lesen zu:
Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial
06.03. -
01.03. 2
27.02. 5
24.02. 3
Seite: 1 2 3 Weiter>>
41 Nachrichten in den letzten 6 Monaten